This site is intended for Healthcare professionals only.

Lupins US arm recalls 12,888 bottles of ulcer drug in US

Lupins US arm recalls 12,888 bottles of ulcer drug in US

New Delhi: Drug firm Lupin’s US arm, Lupin Pharmaceuticals Inc, is recalling 12,888 bottles of Famotidine for oral suspension used in the treatment of ulcers from the American market.

The reason for the recall is current Good Manufacturing Practice (cGMP) deviations, United States Food and Drug Administration (USFDA) said in its latest Enforcement Report.

Lupin Pharmaceuticals Inc is recalling 12,888 bottles of Famotidine for oral suspension USP, 40 mg/5 ml, 50 ml bottle, manufactured by Lupin Ltd at its Goa facility, it added.

The ongoing nation wide voluntary recall is a class III recall, the report said.

Famotidine for oral suspension is indicated for the short-term treatment of active duodenal ulcer, active benign gastric ulcer, and gastroesophageal reflux disease.

As per the USFDA, a class III recall is initiated in “a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences”.

The following two tabs change content below.
Ruby Khatun

Ruby Khatun

Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at Contact no. 011-43720751

Source: PTI
0 comment(s) on Lupins US arm recalls 12,888 bottles of ulcer drug in US

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted